Alopurinol Glenmark 300 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

alopurinol glenmark 300 mg tablety

ipca, produtos farmaceuticos, unipessoal lda, portugalsko - alopurinol - 29 - antirheumatica, antiphlogistica, antiuratica

Alopurinol Glenmark 100 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

alopurinol glenmark 100 mg tablety

ipca, produtos farmaceuticos, unipessoal lda, portugalsko - alopurinol - 29 - antirheumatica, antiphlogistica, antiuratica

Furosemid FMK 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

furosemid fmk 40 mg

farmak international sp. z o.o., poľsko - furosemid - 50 - diuretica

Furosemid Medreg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

furosemid medreg

medreg s.r.o., Česká republika - furosemid - 50 - diuretica

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Európska únia - slovenčina - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).

Eryseng Parvo Európska únia - slovenčina - EMA (European Medicines Agency)

eryseng parvo

laboratorios hipra, s.a. - ošípaných parvovirus, kmeň nadl-2 a erysipelothrix rhusiopathiae, kmeň r32e11 (neaktívne) - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - ošípané - pre aktívnej imunizácie žien ošípaných na ochranu potomstvo proti transplacental infekcie spôsobené ošípaných parvovirus. pre aktívnej imunizácie mužskej a ženskej ošípaných na zníženie klinických príznakov (kožné lézie a horúčka) moru erysipelas spôsobené erysipelothrix rhusiopathiae, sérotyp 1 a sérotyp 2.

Xiliarx Európska únia - slovenčina - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).

Jalra Európska únia - slovenčina - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptín - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).

Galvus Európska únia - slovenčina - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.